Neurocrine Biosciences Operating Lease Income - 2025 (Lessor) remained flat by 0.0% to $3.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $3.50M to $3.50M. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate a robust and stable pipeline of recurring revenue from the leasing segment.
This metric forecasts the rental income expected to be generated from operating leases in a future fiscal year. Unlike f...
Commonly reported in the maturity and future income disclosures of banks with significant operating lease portfolios.
operating_lease_income_2025_lessor| Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $1.70M | $1.70M | $2.70M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M |
| QoQ Change | — | +0.0% | +58.8% | +29.6% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +105.9% | +105.9% | +29.6% | +0.0% | +0.0% |